External application of traditional Chinese medicine for mastitis

Abstract

The utility model discloses a kind of mastitis external application of traditional Chinese medicine, it is related to traditional Chinese medicine external application technical field.Including release film, the upper surface of release film is pasted with application, the outer wall of release film right side is fixedly connected with plastic protective sleeve, the inner chamber of plastic protective sleeve is equipped with medicine supplement structure, release film includes membrane body, the lower surface of application is pasted in membrane body, existing is mostly fixed medicine core external application, and the application is innovatively added medicine supplement structure and plastic protective sleeve.Plastic protective sleeve can seal and keep fresh to supplement medicine core, to avoid drug failure;Medicine supplement structure can accurately tear protective film by No. 1, No. 2 protective film and corresponding connecting belt, character, and supplement medicine core is pasted in the uncovered area of self-contained medicine core. For different patient site size, inflammation range difference, without replacing entire application, just supplement medicine core, both reduce waste, and can make medicine cover lesion comprehensively.

Description

Technical Field

[0001] This utility model relates to the field of traditional Chinese medicine external application techniques, and in particular to a traditional Chinese medicine external application for mastitis. Background Technology

[0002] The development of traditional Chinese medicine (TCM) external application techniques for mastitis is driven by multiple factors. Mastitis commonly affects breastfeeding women, accompanied by redness, swelling, heat, and pain. Traditional oral medications can affect breast milk and irritate the spleen and stomach, while treatments for non-lactating women carry risks of hormonal side effects or surgical damage, thus creating an application space for external application techniques. This technology is supported by the TCM theories of "meridian conduction" and "treating internal diseases externally," selecting TCM herbs that clear heat, reduce swelling, promote blood circulation, and dissipate nodules. These herbs penetrate the skin to act on the lesion and regulate the whole body. Modern technology improves efficacy and convenience by optimizing extraction processes, upgrading carrier materials, and standardizing dosage forms. Furthermore, the approval, medical insurance coverage, and quality standards guaranteed by the national "modernization of TCM" strategy have made it an important means of treating mastitis.

[0003] However, existing technologies still have shortcomings, such as the following:

[0004] Most existing topical dressings use a fixed medicated core design, which cannot adapt to the differences in the size and extent of mastitis lesions among different patients, often resulting in incomplete coverage of the medicated core. This makes it difficult for uncovered lesion areas to receive the medication, affecting the treatment effect, and also requires frequent replacement of the entire dressing, resulting in waste. Utility Model Content

[0005] The purpose of this invention is to provide a traditional Chinese medicine external application patch for mastitis, in order to solve the problem of incomplete coverage of the medicated core in existing patches mentioned in the background art.

[0006] To achieve the above objectives, this utility model provides the following technical solution:

[0007] A traditional Chinese medicine external application for mastitis includes a release film, on the upper surface of which an application patch is attached, and a plastic protective sleeve is fixedly connected to the outer wall on the right side of the release film. The inner cavity of the plastic protective sleeve is provided with a drug replenishment structure.

[0008] The release film includes a film body, which is adhered to the lower surface of the adhesive. An easy-tear line is fixedly connected to the outer wall on the right side of the film body, and one side of the easy-tear line is fixedly connected to one side of the plastic protective sleeve.

[0009] Preferably, the plastic protective case includes a case body, the outer wall on the left side of the case body is fixedly connected to one side of the tear line, and tear openings are provided on the outer walls on both sides of the case body.

[0010] Preferably, the drug replenishment structure includes a first protective film, a first connecting strip fixedly connected to the outer wall of the first protective film, and a first character fixedly connected to the outer wall of the first connecting strip.

[0011] Preferably, a supplementary medication core is adhered to the lower surface of the first protective film, and a second protective film is adhered to the lower surface of the supplementary medication core.

[0012] Preferably, a second connecting strip is fixedly connected to the outer wall of the second protective film, and a second character is fixedly connected to the outer wall of the second connecting strip.

[0013] Preferably, the dressing includes a backing layer, a breathable layer is fixedly connected to the lower surface of the backing layer, and a sweat-absorbing layer is fixedly connected to the lower surface of the breathable layer.

[0014] Preferably, a skin-contact layer is fixedly connected to the lower surface of the sweat-absorbing layer, an adhesive layer is fixedly connected to the lower surface of the skin-contact layer, and a self-contained medicated core is adhered to the middle of the lower surface of the skin-contact layer.

[0015] Compared with the prior art, the beneficial effects of this utility model are:

[0016] Most existing topical dressings use fixed medicated cores. This new dressing innovatively adds a medication replenishment structure and a plastic protective sleeve. The plastic protective sleeve seals and preserves the replenishing medicated core, preventing medication deterioration. The medication replenishment structure, via two protective films and corresponding connecting strips and markings, allows for precise application of the replenishing medicated core to areas not covered by the original core. Addressing the differences in the size and extent of inflammation of various patient sites, it eliminates the need to replace the entire dressing; only the replenishing of the medicated core is required, reducing waste and ensuring complete medication coverage of the lesion. Attached Figure Description

[0017] Figure 1 This is a schematic diagram of the main structure of this utility model;

[0018] Figure 2 This is a schematic diagram of the drug supplement structure of this utility model;

[0019] Figure 3 This is a schematic diagram of the application structure of this utility model from a bottom view;

[0020] Figure 4 This is a schematic cross-sectional view of the backing layer of this utility model.

[0021] In the diagram: 1. Release film; 11. Film body; 12. Tear line; 2. Adhesive; 21. Backing layer; 22. Breathable layer; 23. Sweat-absorbing layer; 24. Skin-contact layer; 25. Adhesive layer; 26. Self-contained medicated core; 3. Plastic protective sleeve; 31. Sleeve body; 32. Tear opening; 4. Medication replenishment structure; 41. Protective film No. 1; 411. Connecting strap No. 1; 412. Character No. 1; 42. Replenishing medicated core; 43. Protective film No. 2; 431. Connecting strap No. 2; 432. Character No. 2. Detailed Implementation

[0022] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.

[0023] like Figure 1 As shown, a traditional Chinese medicine external application for mastitis includes a release film 1, with an application 2 attached to the upper surface of the release film 1 for application to the affected area for treatment. A plastic protective sleeve 3 is fixedly connected to the outer wall of the right side of the release film 1, and the inner cavity of the plastic protective sleeve 3 is provided with a drug replenishment structure 4, so that the plastic protective sleeve 3 seals the drug in the drug replenishment structure 4. The release film 1 includes a film body 11, which is attached to the lower surface of the application 2 to seal the drug on the lower surface of the application 2. An easy-tear line 12 is fixedly connected to the outer wall of the right side of the film body 11, and one side of the easy-tear line 12 is fixedly connected to one side of the plastic protective sleeve 3, so that the plastic protective sleeve 3 can be torn apart from the release film 1 by force. The plastic protective sleeve 3 includes a sleeve body 31, and the outer wall of the left side of the sleeve body 31 is fixedly connected to one side of the easy-tear line 12, so that the connection with the film body 11 can be torn apart by force. Tear openings 32 are provided on the outer walls of both sides of the sleeve body 31, and the interior of the sleeve body 31 can be opened by tearing open the tear openings 32.

[0024] It should be noted that in this embodiment, when applying the topical medication to the affected area, first use a little force to tear the plastic protective sleeve 3 off from one side of the easy-tear line 12, then tear open the sleeve body 31 according to the tear opening 32, take out the medication replenishment structure 4 inside the sleeve body 31, and after attaching the replenishment medication core 42, attach the original medication core 26 and the replenishment medication core 42 to the upper surface for treatment according to the patient's position, and at the same time use the adhesive layer 25 to stick it to the skin surface.

[0025] like Figure 1 - Figure 4As shown, the drug replenishment structure 4 includes a first protective film 41, which prevents contamination from contacting the replenishment core 42. A first connecting strap 411 is fixedly connected to the outer wall of the first protective film 41, facilitating the removal of the first protective film 41 from the upper surface of the replenishment core 42. A first character 412 is fixedly connected to the outer wall of the first connecting strap 411 for marking the operating sequence. The replenishment core 42 is attached to the lower surface of the first protective film 41, allowing it to be transferred and attached to the lower surface of the skin contact layer 24. A second protective film 43 is attached to the lower surface of the replenishment core 42 to prevent contamination. A second connecting strap 431 is fixedly connected to the outer wall of the second protective film 43. The second protective film 43 is easily lifted from the lower surface of the supplementary medicated core 42. The outer wall of the second connecting strip 431 is fixedly connected with the second character 432, which, like the first character 412, is used to mark the operation sequence. The patch 2 includes a backing layer 21, and the lower surface of the backing layer 21 is fixedly connected with a breathable layer 22 to provide breathability. The lower surface of the breathable layer 22 is fixedly connected with a sweat-absorbing layer 23 to absorb sweat. The lower surface of the sweat-absorbing layer 23 is fixedly connected with a skin-contact layer 24, which can be used for direct contact with the skin. The lower surface of the skin-contact layer 24 is fixedly connected with an adhesive layer 25 so that the release film 1 can be adhered to the affected area. The middle of the lower surface of the skin-contact layer 24 is attached with a self-contained medicated core 26 for treating the affected area.

[0026] It should be noted that in this embodiment, after the drug replenishment structure 4 is taken out from the inside of the cover 31, the film 11 on the lower surface of the patch 2 is torn open to expose the lower surface of the patch 2. Then, according to the injured part, different parts are selected to replenish the drug core 42. Starting from the first character 412, the first connecting strap 411 is pulled to tear the first protective film 41 from the upper surface of the replenishment drug core 42. Then, the torn upper surface of the replenishment drug core 42 is aligned with the area that the built-in drug core 26 cannot cover and is attached to the outer wall of the skin contact layer 24. Then, the second character 432 with the second connecting strap 431 is pulled to tear the second protective film 43 from the lower surface of the replenishment drug core 42 to expose the lower surface of the replenishment drug core 42.

[0027] The working principle of this utility model is as follows: When applying topical medication to the affected area, first use a little force to tear the plastic protective sleeve 3 off from one side of the easy-tear line 12. Then, tear open the sleeve body 31 according to the tear opening 32, and take out the medication replenishment structure 4 inside the sleeve body 31. After taking out the medication replenishment structure 4 from the inside of the sleeve body 31, tear open the film body 11 on the lower surface of the dressing 2 to expose the lower surface of the dressing 2. Then, according to the injured part, select different parts to replenish the medication core 42. Starting from the first character 412, pull the first connecting strap 411 to tear the first protective film 41 from the upper surface of the medication core 42. Then, align the torn upper surface of the medication core 42 with the area that the built-in medication core 26 cannot cover, and stick it to the outer wall of the skin contact layer 24. Then, pull the second character 432 with the second connecting strap 431 to tear the second protective film 43 from the lower surface of the medication core 42 to expose the lower surface of the medication core 42.

[0028] After applying the supplementary medicated core 42, apply the original medicated core 26 and the supplementary medicated core 42 to the upper surface for treatment, depending on the location of the patient, and use the adhesive layer 25 to stick it to the skin surface.

[0029] The foregoing has shown and described the basic principles, main features, and advantages of this utility model. Those skilled in the art should understand that this utility model is not limited to the above embodiments. The embodiments and descriptions in the specification are merely illustrative of the principles of this utility model. Various changes and modifications can be made to this utility model without departing from its spirit and scope, and all such changes and modifications fall within the scope of the claims. The scope of protection of this utility model is defined by the appended claims and their equivalents.

Claims

1. A traditional Chinese medicine external application for mastitis, comprising a release film (1), characterized in that: The release film (1) has an adhesive patch (2) pasted on its upper surface. A plastic protective sleeve (3) is fixedly connected to the outer wall on the right side of the release film (1). The inner cavity of the plastic protective sleeve (3) is provided with a drug replenishment structure (4). The release film (1) includes a film body (11), which is attached to the lower surface of the dressing (2). An easy-tear line (12) is fixedly connected to the outer wall on the right side of the film body (11), and one side of the easy-tear line (12) is fixedly connected to one side of the plastic protective sleeve (3).

2. The traditional Chinese medicine external application patch for mastitis according to claim 1, characterized in that: The plastic protective cover (3) includes a cover body (31), the outer wall on the left side of the cover body (31) is fixedly connected to one side of the tear line (12), and tear openings (32) are provided on the outer walls on both sides of the cover body (31).

3. The traditional Chinese medicine external application patch for mastitis according to claim 1, characterized in that: The drug supplement structure (4) includes a first protective film (41), the outer wall of which is fixedly connected to a first connecting strip (411), and the outer wall of the first connecting strip (411) is fixedly connected to a first character (412).

4. The traditional Chinese medicine external application patch for mastitis according to claim 3, characterized in that: A supplementary medicated core (42) is attached to the lower surface of the first protective film (41), and a second protective film (43) is attached to the lower surface of the supplementary medicated core (42).

5. The traditional Chinese medicine external application patch for mastitis according to claim 4, characterized in that: The outer wall of the second protective film (43) is fixedly connected to the second connecting strip (431), and the outer wall of the second connecting strip (431) is fixedly connected to the second character (432).

6. The traditional Chinese medicine external application patch for mastitis according to claim 1, characterized in that: The patch (2) includes a backing layer (21), a breathable layer (22) is fixedly connected to the lower surface of the backing layer (21), and a sweat-absorbing layer (23) is fixedly connected to the lower surface of the breathable layer (22).

7. The traditional Chinese medicine external application patch for mastitis according to claim 6, characterized in that: A skin-contact layer (24) is fixedly connected to the lower surface of the sweat-absorbing layer (23), an adhesive layer (25) is fixedly connected to the lower surface of the skin-contact layer (24), and a self-contained medicated core (26) is pasted in the middle of the lower surface of the skin-contact layer (24).

Images